CNSX:ASTI - Aquarius Surgical Technologies Stock Price, News & Analysis

Today's Range N/A
50-Day Range
MA: $0.40
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. It provides minimally invasive medical laser systems and consumables for various medical disciplines, primarily for the treatment of benign prostatic hyperplasia. The company also offers solutions comprising clinical education, service, support, and maintenance. Its portable benign prostatic hyperplasia laser device supports all available fiber delivery systems. The company was formerly known as Aquarius Coatings Inc. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.

Industry, Sector and Symbol

Industry Solar
SectorComputer and Technology



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive ASTI News and Ratings via Email

Sign-up to receive the latest news and ratings for ASTI and its competitors with MarketBeat's FREE daily newsletter.

Aquarius Surgical Technologies (CNSX:ASTI) Frequently Asked Questions

What is Aquarius Surgical Technologies' stock symbol?

Aquarius Surgical Technologies trades on the CNSX under the ticker symbol "ASTI."

Has Aquarius Surgical Technologies been receiving favorable news coverage?

Media stories about ASTI stock have been trending negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aquarius Surgical Technologies earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Aquarius Surgical Technologies.

Who are some of Aquarius Surgical Technologies' key competitors?

Some companies that are related to Aquarius Surgical Technologies include SMA Solar Technology (S92), Verditek (VDTK), Enerdynamic Hybrid Technologies (EHT), PV Crystalox Solar (PVCS) and UGE International (UGE).

Who are Aquarius Surgical Technologies' key executives?

Aquarius Surgical Technologies' management team includes the folowing people:
  • Mr. N. Gary Van Nest B.Comm., M.B.A, CEO & Vice Chairman (Age 83)
  • Mr. Gordon S. Willox, Pres, CTO & Director
  • Mr. Lorne Stewart MacFarlane, Chief Financial Officer
  • Mr. Christopher H. Freeman, Sec.

How do I buy shares of Aquarius Surgical Technologies?

Shares of ASTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Aquarius Surgical Technologies' official website?

The official website for Aquarius Surgical Technologies is

How can I contact Aquarius Surgical Technologies?

The company can be reached via phone at 720-872-5000.

MarketBeat Community Rating for Aquarius Surgical Technologies (CNSX ASTI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  22
MarketBeat's community ratings are surveys of what our community members think about Aquarius Surgical Technologies and other stocks. Vote "Outperform" if you believe ASTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel